Urinary incontinence in spinal cord injury patients could be treated using Botox, new evidence suggests.
Allergen Inc has announced that the Irish Medicines Board supports the use of this treatment to treat urinary incontinence in spinal cord injury and multiple sclerosis patients.
Many patients with these conditions have neurogenic detrusor overactivity, meaning their bladders contract during the filling stage, when they should be relaxed.
Injecting Botox into the bladder muscle causes the involuntary contractions to subside, increasing bladder activity and cutting urinary leaking incidents.
Douglas Ingram, chief executive officer of European Allergan, said: "For many people with spinal cord injury or multiple sclerosis, gaining effective control over their bladder and staying dry can be a significant step towards improving daily functioning and overall quality of life."